Dossus, Laure

Ovarian cancer risk factors by histologic subtype: An analysis from the ovarian cancer cohort consortium

Wentzensen, N., Poole, E. M., Trabert, B., White, E., Arslan, A. A., Patel, A. V., Setiawan, V. W., Visvanathan, K., Weiderpass, E., Adami, H.-O., et al. (2016) · Journal of Clinical Oncology

Ovarian cancer diagnosis and treatmentCancer Risks and Factors

Cited by 514

Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women

Lukanova, A., Lundin, E., Zeleniuch-Jacquotte, A., Muti, P., Mure, A., Rinaldi, S., Dossus, L., Micheli, A., Arslan, A., Lenner, P., et al. (2004) · European Journal of Endocrinology

Growth Hormone and Insulin-like Growth FactorsCancer Risks and Factors

Cited by 315

Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and nutrition (EPIC) study

Ferrari, P., Licaj, I., Muller, D. C., Kragh Andersen, P., Johansson, M., Boeing, H., Weiderpass, E., Dossus, L., Dartois, L., Fagherazzi, G., et al. (2014) · BMJ Open

Alcohol Consumption and Health EffectsSubstance Abuse Treatment and Outcomes

Cited by 105

Tumor necrosis factor (TNF)‐α, soluble TNF receptors and endometrial cancer risk: The EPIC study

Dossus, L., Becker, S., Rinaldi, S., Lukanova, A., Tjønneland, A., Olsen, A., Overvad, K., Chabbert‐Buffet, N., Boutron‐Ruault, M., Clavel‐Chapelon, F., et al. (2011) · International Journal of Cancer

Cancer Risks and FactorsEndometrial and Cervical Cancer Treatments

Cited by 75

N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort

Pesch, B., Gawrych, K., Rabstein, S., Weiss, T., Casjens, S., Rihs, H.-P., Ding, H., Angerer, J., Illig, T., Klopp, N., et al. (2013) · Cancer Epidemiology, Biomarkers & Prevention

Pharmacogenetics and Drug MetabolismCarcinogens and Genotoxicity Assessment

Cited by 35